Co-Diagnostics Reports Solid First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Co-Diagnostics (CODX) Tops Q1 EPS by 17c
May 12, 2022 4:12 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q1 EPS of $0.34, $0.17 better than the analyst estimate of $0.17. Revenue for the quarter came in at $22.7 million versus the consensus estimate of $20.17 million.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
... More


